Comparing Complications, Functional And Oncological Outcomes Of Partial Versus Total Adrenalectomy: A Systematic Review And Meta-Analysis Of Literature
Urology Journal,
Vol. 22 No. 06 (2025),
11 January 2026
,
Page 269-282
https://doi.org/10.22037/uj.v22i.8785
Abstract
Purpose: Surgical management is a key component in treating adrenal masses, particularly when they are functional or large. However, the choice between partial adrenalectomy (PA) and total adrenalectomy (TA) remains controversial. Therefore, this systematic review and meta-analysis aimed to evaluate whether surgical outcomes differ between patients undergoing PA versus TA.
Materials and methods: Following PRISMA 2020 guidelines, we systematically searched PubMed, Scopus, Web of Science, and the Cochrane Library for studies published up to April 2025. Nineteen studies were included, and methodological quality was assessed using the Newcastle–Ottawa Scale (NOS). A random-effects meta-analysis was conducted to estimate pooled outcomes.
Results: A total of 19 studies comprising 3,165 patients were included, of whom 1,084 underwent partial adrenalectomy (PA) and 2,081 underwent total adrenalectomy (TA). PA was associated with a significantly higher risk of tumor recurrence compared with TA (RR = 2.64, 95% CI 1.55-4.51), while no significant differences were observed for metastasis or mortality. In contrast, PA significantly reduced the risk of postoperative steroid dependence (RR = 0.44, 95% CI 0.34-0.55) and adrenal insufficiency (RR = 0.49, 95% CI 0.34-0.70). Perioperative complications were less frequent following PA (RR = 0.56, 95% CI 0.40-0.78), particularly mild complications, with no differences in severe complications. There were no significant differences in operative time or intraoperative blood loss between the two techniques. Subgroup analyses demonstrated higher recurrence rates in pheochromocytoma among patients undergoing PA, compared with Conn’s adenoma. Perioperative complications were less frequent in PA in patients with Conn’s adenoma. No significant differences were observed regarding surgical laterality (left vs. right) or the operative approach (transperitoneal vs. retroperitoneal laparoscopic / robotic surgery).
Conclusion: PA offers superior preservation of adrenal function and fewer mild perioperative complications compared with TA, but shows a higher risk of tumor recurrence in pheochromocytoma patients. PA was not associated with higher recurrence in Conn’s patients. Other surgical and oncological outcomes were similar, underscoring the need to individualize the choice of procedure based on tumor type and patient factors.
- partial adrenalectomy
- cortical-sparing adrenalectomy
- total adrenalectomy
- complications
- Functional outcomes
- Oncological outcomes
- Cushing Syndrome
- Conn's syndrome
- Pheochromocytoma
How to Cite
References
1. Barat M, Cottereau AS, Gaujoux S, Tenenbaum F, Sibony M, Bertherat J, et al. Adrenal Mass Characterization in the Era of Quantitative Imaging: State of the Art. Cancers (Basel). 2022;14.
2. Vierhapper H. Adrenocortical tumors: clinical symptoms and biochemical diagnosis. Eur J Radiol. 2002;41:88-94.
3. Falcetta P, Orsolini F, Benelli E, Agretti P, Vitti P, Di Cosmo C, et al. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study. Endocrine. 2021;71:178-88.
4. Bradley CT, Strong VE. Surgical management of adrenal metastases. J Surg Oncol. 2014;109:31-5.
5. Sherlock M, Scarsbrook A, Abbas A, Fraser S, Limumpornpetch P, Dineen R, et al. Adrenal Incidentaloma. Endocr Rev. 2020;41:775-820.
6. Mody RN, Remer EM, Nikolaidis P, Khatri G, Dogra VS, Ganeshan D, et al. ACR Appropriateness Criteria® adrenal mass evaluation: 2021 update. J Am Coll Radiol. 2021;18:S251-S67.
7. Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J, et al. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2023;189:G1-G42.
8. Castinetti F, Taieb D, Henry JF, Walz M, Guerin C, Brue T, et al. MANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytoma. Eur J Endocrinol. 2016;174:R9-R18.
9. Procopio PF, Pennestrì F, De Crea C, Voloudakis N, Bellantone R, Raffaelli M. Outcome of Partial Adrenalectomy in MEN2 Syndrome: Personal Experience and Systematic Review of Literature. Life (Basel). 2023;13.
10. Onuma AE, Sun SH, Miller BS. Partial adrenalectomy: evaluation and management--a clinical practice review. Laparosc Surg. 2023;7.
11. Simforoosh N, Soltani MH, Shemshaki H, Bonakdar Hashemi M, Dadpour M, Kashi AH. Symptom Resolution and Recurrence Outcomes after Partial Versus Total Laparoscopic Adrenalectomy: 13 years of Experience with Medium-Long Term Follow up. Urol J. 2020;18:165-70.
12. Neumann HPH, Tsoy U, Bancos I, Amodru V, Walz MK, Tirosh A, et al. Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy. JAMA Netw Open. 2019;2:e198898.
13. Xu K, Langenhuijsen JF, Viëtor CL, Feelders RA, van Ginhoven TM, Elhassan YS, et al. PRAP study-partial versus radical adrenalectomy in hereditary pheochromocytomas. Eur J Endocrinol. 2024;191:345-53.
14. Billmann F, Billeter A, Thomusch O, Keck T, El Shishtawi S, Langan EA, et al. Minimally invasive partial versus total adrenalectomy for unilateral primary hyperaldosteronism-a retrospective, multicenter matched-pair analysis using the new international consensus on outcome measures. Surgery. 2021;169:1361-70.
15. Lu M, Cheng C, Zhang Y. Laparoscopic versus conventional open peritoneal dialysis catheter insertion in China: a meta-analysis. Urol J. 2023;20:81-89.
16. Soltani MH, Hossein Kashi A, Farshid S, Mantegy SJ, Valizadeh R. Transperitoneal laparoscopic pyelolithotomy versus percutaneous nephrolithotomy for treating patients with staghorn kidney stones: a randomized clinical trial. Urol J. 2021;19:28 33.
17. Simforoosh N, Simforoosh F, Dadpour M, Fowzi Fard H, Borumandnia N, Hasani H. Oncologic outcomes following positive surgical margins in patients who underwent open versus laparoscopic partial nephrectomy. Urol J. 2022;20:17 21.
18. Yorulmaz EM, Köse O, Özcan S, Görgel SN, Akın Y. The Controlling Nutritional Status (CONUT) Score as a Predictor of Local Recurrence in Patients Underwent Partial Nephrectomy Alongside the R.E.N.A.L. Nephrometry Score. Urol J. 2024;21:313-319.
19. Amanollahi Soudmand S, Hoseinzadeh S, Moosavi M, Simforoosh N. Efficacy and Safety of 177Lu-PSMA-617 in Combination with Radical Prostatectomy and Bilateral Orchiectomy in Men with Castrate-Sensitive Metastatic Prostate Cancer: A Pilot Study. Urol J. 2024;21:374-383.
20. Afshar Safavi M, Niknam H, Okhovatian F, Akbarzadeh Baghban A, Naimi SS, Roostayi MM. The Effect of Physiotherapy on Erectile Dysfunction Secondary to Prostatic Adenectomy: A Randomized Control Trial Study. Urol J. 2024;21:331-339.
21. Maghsoudi R, Etemadian M, Kashi AH, Ranjbaran A. The Association of Stone Opacity in Plain Radiography with Percutaneous Nephrolithotomy Outcomes and Complications. Urol J. 2016;13:2899-2902.
22. Maghsoudi R, Etemadian M, Kashi AH, Mehravaran K. Management of Colon Perforation During Percutaneous Nephrolithotomy: 12 Years of Experience in a Referral Center. J Endourol. 2017;31:1032-1036.
23. Simforoosh N, Basiri A, Tabibi A, Javanmard B, Kashi AH, Soltani MH, Obeid K. Living Unrelated Versus Related Kidney Transplantation: A 25-Year Experience with 3716 Cases. Urol J. 2016 Mar
24. Wan, X., Wang, W., Liu, J. et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
25. Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. 2011;2:1-12.
26. Higgins JP, Savović J, Page MJ, Elbers RG, Sterne JA. Assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions. Hoboken, NJ, USA: Wiley; 2019. p. 205-28.
27. Shaikh S, Nagendra L, Shaikh S, Pappachan JM. Adrenal Failure: An Evidence-Based Diagnostic Approach. Diagnostics. 2023;13:1812.
28. Téoule, P., Bartel, F., Birgin, E., Rückert, F., & Wilhelm, T. J. (2018). The Clavien-Dindo Classification in Pancreatic Surgery: A Clinical and Economic Validation. Journal of Investigative Surgery, 32(4), 314–320.
29. Yip L, Duh QY, Wachtel H, Jimenez C, Sturgeon C, Lee C, et al. American Association of Endocrine Surgeons Guidelines for Adrenalectomy: Executive Summary. JAMA Surg. 2022;157:870-7.
30. Zawadzka K, Tylec P, Małczak P, Major P, Pędziwiatr M, Pisarska-Adamczyk M. Total versus partial adrenalectomy in bilateral pheochromocytoma - a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2023;14:1127676.
31. Li KP, Duan X, Yang XS, Huang J, Wu T. Partial versus total adrenalectomy for the treatment of unilateral aldosterone-producing adenoma: a systematic review and meta-analysis. Updates Surg. 2021;73:2301-13.
32. Alesina PF, Kniazeva P, Pinto G, Pontin A, Walz MK. Long-term outcome of retroperitoneoscopic partial versus total adrenalectomy in patients with Cushing's syndrome. World J Surg. 2024;48:121-9.
33. Nagaraja V, Eslick GD, Edirimanne S. Recurrence and functional outcomes of partial adrenalectomy: a systematic review and meta-analysis. Int J Surg. 2015;16:7-13.
34. Reisch N, Peczkowska M, Januszewicz A, Neumann HP. Pheochromocytoma: presentation, diagnosis and treatment. J Hypertens. 2006;24:2331-9.
35. Chung R, O'Shea A, Sweeney AT, Mercaldo ND, McDermott S, Blake MA. Hereditary and sporadic pheochromocytoma: comparison of imaging, clinical, and laboratory features. AJR Am J Roentgenol. 2022;219:97-109.
36. Wagner-Bartak NA, Baiomy A, Habra MA, Mukhi SV, Morani AC, Korivi BR, et al. Cushing syndrome: diagnostic workup and imaging features, with clinical and pathologic correlation. AJR Am J Roentgenol. 2017;209:19-32.
37. Hradova D, Yuzvenko V. Bilateral adrenal pathology: Conn syndrome and autonomous cortisol secretion. Ukr Sci Med Youth J. 2023;141:14-8.
38. Kaye DR, Storey BB, Pacak K, Pinto PA, Linehan WM, Bratslavsky G. Partial adrenalectomy: underused first line therapy for small adrenal tumors. J Urol. 2010;184:18-25.
39. Shen WT, Lee J, Kebebew E, Clark OH, Duh QY. Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive cases. Arch Surg. 2006;141:771-4; discussion 4-6.
40. Kulshreshtha B, Arora A, Aggarwal A, Bhardwaj M. Prolonged adrenal insufficiency after unilateral adrenalectomy for Cushing's Syndrome. Indian J Endocrinol Metab. 2015;19:430-2.
41. Kahramangil B, Montorfano L, Gutierrez D, Erten O, Zhou K, Li D, et al. Biochemical assessment of adrenal insufficiency after adrenalectomy for non-cortisol secreting tumors: clinical correlation and recommendations. Surg Endosc. 2022;36:7638-46.
42. Silvinato A, Bernardo WM, Branco AW. Total and partial laparoscopic adrenalectomy. Rev Assoc Med Bras (1992). 2019;65:578-85.
43. Balcı M, Tuncel A, Güzel Ö, Aslan Y, Keten T, Köseoğlu E, et al. Evaluation of the complications in transperitoneal laparoscopic renal and adrenal surgery with Clavien-Dindo classification. Turk J Urol. 2016;42:70-3.
44. Walz MK, Peitgen K, Diesing D, Petersenn S, Janssen OE, Philipp T, et al. Partial versus total adrenalectomy by the posterior retroperitoneoscopic approach: early and long-term results of 325 consecutive procedures in primary adrenal neoplasias. World J Surg. 2004;28:1323-9.
45. Porpiglia F, Destefanis P, Bovio S, Allasino B, Orlandi F, Fontana D, et al. Cortical-sparing laparoscopic adrenalectomy in a patient with multiple endocrine neoplasia type IIA. Horm Res. 2002;57:197-9.
- Abstract Viewed: 136 times
- 8785-pdf Downloaded: 105 times